PATENT CLAIM ANALYSIS

Application Number: 16103375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "253130"]

Abstract:
The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmue disorders.

Claim (Index 6):
The method according to  claim 5 , wherein W is \u2014C\u2261C\u2014.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.30303
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705200', '15552442', '14346359', '13891067', '13227130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.820792366892957
- 35 USC 102 Novelty (BERT): 0.608126174024554
- Combined Prediction Score: 0.7995257476061166
- Mean Citation Score: 448.057326
- Max Citation Score: 794.0231
- Similarity Product: 458.1034507221103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test